Our Science

We constantly challenge ourselves to expand our scientific expertise, increase our technological understanding, and pursue our passion.

  • Top researchers

    (in terms of total citations)

    1,200 researchers and scientists
    and 135 postdocs consistently published in prestigious peer‑reviewed journals

  • Non-Expired Patents

    Appromimately 10,500 current, non‑expired patents worldwide secured by our scientists

  • Patents Pending

    Approximately 7,000 patent applications pending worldwide

  • Top researchers
    (in terms of total citations)
    • 1,200 researchers and scientists
    • and 135 postdocs consistently published in prestigious peer‑reviewed journals
  • Non-Expired Patents

    Appromimately 10,500 current, non‑expired patents worldwide secured by our scientists

  • Patents Pending

    Approximately 7,000 patent applications pending worldwide

Our Broad Expertise

Genentech became a member of the Roche Group in 2009, creating one of the most impressive combined portfolios in the pharmaceutical industry and further accelerating our search for innovative healthcare solutions.

Roche—the world’s largest biotech company

Leads with a focus on disease areas that include immunology, neuroscience, and oncology.

World leader in biologics manufacturing

The combined organization of Genentech and Roche has more FDA-approved manufacturing capacity for the production of biotech medicines than any other company.

Our Commitment

We have been providing assistance to patients since our first medicine was approved in 1985.
To date, we have helped more than 1.2 million patients access the medicines they need. In 2014 alone:

  • More than 180,000 patients were helped in accessing the Genentech medicines they needed.
  • Approximately 25,000 patients who qualified were provided free medicine through the Genentech® Access to Care Foundation (GATCF).*
  • More than 80,000 patients received co-pay support through our donations to independent non-profit organizations.*

*In 2014. Patients must meet certain criteria.